 |
Doreen Agnese, MD
(614) 293-6694
doreen.agnese@osumc.edu Recent Publications
Agnese DM, Lowry SF. Back to the Future: Is Lipid A an Appropriate Target for the Therapy of Sepsis? Critical Care Medicine, August 2000; 28(8): 3084-3086. Agnese DM, Calvano JE, Hahm SJ, Reddell M, Coyle SM, Calvano SE, Lowry SF. Genetic regulation of monocyte apoptosis in endotoxemic volunteers. Surgical Forum, 2001; Vol 52. Calvano JE, Agnese DM, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human Toll-like receptor 4 (hTLR4) mutations are associated with an increased incidence of gram-negative infections and increased mortality. Surgical Forum, 2001; Vol 52. Agnese DM, Calvano JE, Hahm SJ, Calvano SE, Lowry SF. Insulin-like Growth Factor Binding Protein-3 is Upregulated in LPS-treated THP-1 Cells. Surgical Infections, 2002 Summer; 3(2): 119-126. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human Toll-like receptor 4 (hTLR4) mutations, but not CD14 polymorphisms, are associated with an increased incidence of gram-negative infections. Journal of Infectious Diseases, November 15,2002; 186(10): 1522-5. Calvano JE, Um JY, Agnese DM, Hahm SJ, Kumar A, Coyle SM, Calvano SE, Lowry SF. Influence of the TNF-a and TNF-ß polymorphisms upon infectious risk and outcome in surgical intensive care patients. Surgical Infections, 2003; 4(2): 163-169. Burak WE, Agnese DM, Povoski SP, Yanssens TL, Bloom KJ, Wakely PE, Spigos DG. Radiofrequency ablation of invasive breast cancer followed by delayed surgical excision. Cancer, October 1, 2003; 98(7): 1369-1376. Agnese DM, Abdessalam SF, Burak WE, Magro CM, Pozderac RV, Walker MJ. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery, October 2003; 134(4): 542-547. Calvano JE, Agnese DM, Um JY, Goshima M, Singhal R, Coyle SM, Reddell MT, Kumar A, Calvano SE, Lowry SF. Modulation of the LPS receptor complex (CD14, TLR4, MD-2) and TLR2 in SIRS positive patients with and without infection: relationship to tolerance. Shock, 2003; 20(5): 415-419. Agnese DM, Williams J, Burak WE. Isolated supraclavicular lymph node recurrence after breast conservation surgery and negative axillary sentinel node biopsy. The Breast Journal, November 2003; 9(6): 501-502. Agnese DM, Abdessalam SF, Burak WE, Arnold MW, Soble D, Hinckle GH, Young D, Khazelli MB, Martin EW. Pilot study using humanized CC49 monoclonal antibody (HuCC49?CH2 Mab) to localize recurrent colorectal carcinoma. Annals of Surgical Oncology, 2003; 11(2): 197-202. Chandler JJ, Agnese DM. “Head and Neck Lesions,” Fundamentals of Clinical Surgery, in press. Burak WE, Agnese DM, Povoski SP. The Surgical Management of Early Stage Invasive Breast Cancer: Emphasis on New Technology. Current Problems in Surgery. In press. Agnese DM, Yusuf F, Wilson JL, Shapiro CL, Lehman A, Burak WE. Trends in breast cancer presentation and care according to age in a single institution. Accepted to The American Journal of Surgery, June 7, 2004; in press. Agnese DM, Kaufman HJ, Lehman AM, Kocak E, Burak WE, Magro CM, Walker MJ. The role of regression as a predictor of nodal status in melanoma in the era of sentinel node biopsy. Submitted to Annals of Surgical Oncology, June 9, 2004. Agnese DM. The genetics of breast cancer: what the general surgeon should know. General Surgery News. July 2004. Agnese DM, Yusuf F, Wilson JL, Shapiro CL, Lehman A, Burak WE. Trends in breast cancer presentation and care according to age in a single institution. The American Journal of Surgery 2004; 188(4): 437-439. Burak WE, Agnese DM, Povoski SP. Advances in the Surgical Management of Early Stage Invasive Breast Cancer. Current Problems in Surgery 2004; 44(11): 882-935. Xiao J, Horst S, Hinkle G, Cao X, Kocak E, Fang J, Young D, Khazaeli M, Agnese D, Sun D, Martin E. Pharmacokinetics and Clinical Evaluation of (125)I-Radiolabeled Humanized CC49 Monoclonal Antibody (HuCC49DeltaC(H)2) in Recurrent and Metastatic Colorectal Cancer Patients. Cancer Biother Radopharm, 2005 ; 20(1): 16-26. Agnese DM, Burak WE. Ablative Approaches to the Minimally Invasive Treatment of Breast Cancer. The Cancer Journal, 2005, 11(1): 77-82. Agnese DM. Advances in Breast Imaging. Surgical Technology International XIV 2005; 14: 51-56. Agnese DM. Battle of the BRCA1/BRCA2 (offspring) sex ratios: truth or consequences? J Med Genet, 2006, 43: 201-202. Povoski SP, Olsen JO, Young DC, Clarke J, Burak WE, Walker MJ, Carson WE, Yee LD, Agnese DM, Pozderac RV, Hall NC, Farrar WB. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol 2006; 13 (11): 1412-21. Agnese DM, Hampel H, Farrar WB. Utilization of genetic counseling by surgical oncologists: education a must. Clinical Genetics, 2006; 70 (6): 524-5. Povoski SP, Young DC, Walker MJ, Carson WE, Yee LD, Agnese DM, Farrar WB. Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery. World J Surg Oncol 2007; 5 (1): 18. Agnese DM, Souba WW, Farrar WB. The Best in Surgical Thinking: What the General Surgeon Should Know About Hereditary Breast and Colon Cancer. What’s New in ACS Surgery. April 2007. Allain DC, Sweet K, Agnese DM. Management options after prophylactic surgeries in mutation positive BRCA women: a review. Cancer Control 2007; 14 (4): 330-7. Agnese DM, Maupin R, Tillman B, Pozderac RD, Magro C, Walker MJ. Head and neck melanoma in the sentinel node era. Archives of Otolaryngology—Head & Neck Surgery, in press.
Book Chapters
Chandler JJ, Agnese DM. "Head and Neck Lesions," Learning Surgery: The Surgery Clerkship Manual, New York: Springer-Verlag, 2005, 177-199. Agnese DM, Povoski SP, Souba WW. “Benign Breast Disease,” ACS Surgery: Principles and Practice, Web MD, Inc. 2007. Agnese DM, Povoski SP, Souba WW. “Breast Cancer,” ACS Surgery: Principles and Practice, Web MD, Inc. 2007.
|
